Histone deacetylase 9

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 7291492
APP PUB NO 20050130146A1
SERIAL NO

10491372

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The identification and cloning of histone deacetylase 9 (HDAC9) is disclosed, and in particular full length HCAC9 polypeptides and HDAC9 polypeptides which have deacetylase activity, and to nucleic acid molecules encoding these polypeptides. The uses of these polypeptides and nucleic acid molecules are disclosed, for example for screening for compounds that are capable of modulating HDAC9 biological activity.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
INSTITUTE OF CANCER RESEARCH THE123 OLD BROMPTON ROAD LONDON SW7 3RP

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Guidez, Fabien London, GB 1 3
Petrie, Kevin Madrid, ES 1 3
Zelent, Arthur London, GB 2 30

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation